Correlation Between Oncology Pharma and Alpha Cognition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncology Pharma and Alpha Cognition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncology Pharma and Alpha Cognition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncology Pharma and Alpha Cognition, you can compare the effects of market volatilities on Oncology Pharma and Alpha Cognition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncology Pharma with a short position of Alpha Cognition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncology Pharma and Alpha Cognition.

Diversification Opportunities for Oncology Pharma and Alpha Cognition

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Oncology and Alpha is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Oncology Pharma and Alpha Cognition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Cognition and Oncology Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncology Pharma are associated (or correlated) with Alpha Cognition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Cognition has no effect on the direction of Oncology Pharma i.e., Oncology Pharma and Alpha Cognition go up and down completely randomly.

Pair Corralation between Oncology Pharma and Alpha Cognition

Given the investment horizon of 90 days Oncology Pharma is expected to generate 5.42 times more return on investment than Alpha Cognition. However, Oncology Pharma is 5.42 times more volatile than Alpha Cognition. It trades about 0.26 of its potential returns per unit of risk. Alpha Cognition is currently generating about 0.05 per unit of risk. If you would invest  58.00  in Oncology Pharma on August 31, 2024 and sell it today you would lose (57.99) from holding Oncology Pharma or give up 99.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy81.65%
ValuesDaily Returns

Oncology Pharma  vs.  Alpha Cognition

 Performance 
       Timeline  
Oncology Pharma 

Risk-Adjusted Performance

29 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Oncology Pharma are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Oncology Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Alpha Cognition 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Cognition are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting technical and fundamental indicators, Alpha Cognition reported solid returns over the last few months and may actually be approaching a breakup point.

Oncology Pharma and Alpha Cognition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncology Pharma and Alpha Cognition

The main advantage of trading using opposite Oncology Pharma and Alpha Cognition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncology Pharma position performs unexpectedly, Alpha Cognition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Cognition will offset losses from the drop in Alpha Cognition's long position.
The idea behind Oncology Pharma and Alpha Cognition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes